Acne fulminans , also known as acne maligna, is a rare and very severe form of acne conglobata associated with systemic symptoms. It appears suddenly in a person with inflammatory acne and is characterized by fever, inflammation and aching of joints especially hips and knees. Acne-fulminans predominantly affects young males aged 13 to 22 years with a history of acne.
Normal severe acne vulgaris is called cystic acne. When
cystic acne spreads and worsens, it turns into acne conglobata. Acne-fulminans
is an even more severe form of acne conglobata. It comes on very suddenly. It results from
unsuccessfully treated acne conglobata. So far, only about 100 cases have been
documented, and it appears to be occurring less frequently .
Although the exact cause of acne-fulminans is not known, it has been associated with increased androgens (male hormones), autoimmune complex disease and genetic predisposition. It is also caused by immunological response to high androgen levels and antigens released from the acne-causing bacterium P. acnes.
The primary features of this disease
include sudden onset, severe and often ulcerating acne, fever and
polyarthritis. When it is severe and ulcerating, They will crust up, causing
cohesion to any fabric the sores touch, which is extremely painful to remove.
As a result, it is recommended to sleep on one's sides until the cystic
condition subsides, in order to avoid any uncomfortable situations.
Acne-fulminans is characterised by:
Patients with acne-fulminans should consult a skin care expert urgently. in order to manage this disease, several medications are usually required for a long period of time, possibly several months or longer. These medications may include:
Tags
comedones, whiteheads, blackheads, acne conglobata, cystic acne, nodular acne, acne scar, laser treatment
Irresistible Acne Remedies. This free newsletter is delivered monthly, straight to your INBOX. It covers all new pages since the last issue. Sign up here...
New! Comments
Have your say about what you just read! Leave me a comment in the box below.